BPIQ-I
BPIQ-I (PD 159121) is a potent and ATP-competitive EGFR tyrosine kinase inhibitor.. BPIQ-I shows anti-proliferative actively.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 174709-30-9
- Formule: C16H12BrN5
- Masse moléculaire:354.20
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Activité biologique
-
Chemical Information
- Pureté et documentation
- Références
-
Help & FAQs
Voir tous les produits spécifiques à Isoform EGFR
More
Activité biologique
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| A-431 | IC50 |
0.025 nM
Compound: 12
|
Inhibition of tyrosine kinase activity of Epidermal growth factor receptor from human A431 carcinoma cells
Inhibition of tyrosine kinase activity of Epidermal growth factor receptor from human A431 carcinoma cells
|
[PMID: 8632415] |
BPIQ-I (0-50 µM; 3 days) shows antiproliferative activity with EC50s of >50, 30, >50, 6.5, >50 µM for A-431, MDA-MB-468, U-87, SKOV-3, MDAMB-231 cells, respectively[1].
BPIQ-I (10 nM) blocks erbB RTKs by competing with ATP, eliminating the CO2 sensitivity[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:A-431, MDA-MB-468, U-87, SKOV-3, MDAMB-231 cells
-
Concentration:0-50 µM
-
Incubation Time:3 days
-
Result:Inhibited cells growth with EC50s of >50, 30, >50, 6.5, >50 µM for A-431, MDA-MB-468, U-87, SKOV-3, MDAMB-231 cells, respectively.
Chemical Information
-
CAS No. 174709-30-9
-
Masse moléculaire 354.20
-
Formule C16H12BrN5
-
SMILES
CN1C=NC2=CC3=C(NC4=CC=CC(Br)=C4)N=CN=C3C=C21
-
Synonyms
PD 159121
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
[1]. Rae JM, et al. Evaluation of novel epidermal growth factor receptor tyrosine kinase inhibitors. Breast Cancer Res Treat. 2004 Jan;83(2):99-107. [Content Brief]
[2]. Zhou Y, et al. Role of a tyrosine kinase in the CO2-induced stimulation of HCO3- reabsorption by rabbit S2 proximal tubules. Am J Physiol Renal Physiol. 2006 Aug;291(2):F358-67. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
BPIQ-I Related Classifications
HY-112405 Related Classifications
Powered by Bioz